<code id='E58EF13CEA'></code><style id='E58EF13CEA'></style>
    • <acronym id='E58EF13CEA'></acronym>
      <center id='E58EF13CEA'><center id='E58EF13CEA'><tfoot id='E58EF13CEA'></tfoot></center><abbr id='E58EF13CEA'><dir id='E58EF13CEA'><tfoot id='E58EF13CEA'></tfoot><noframes id='E58EF13CEA'>

    • <optgroup id='E58EF13CEA'><strike id='E58EF13CEA'><sup id='E58EF13CEA'></sup></strike><code id='E58EF13CEA'></code></optgroup>
        1. <b id='E58EF13CEA'><label id='E58EF13CEA'><select id='E58EF13CEA'><dt id='E58EF13CEA'><span id='E58EF13CEA'></span></dt></select></label></b><u id='E58EF13CEA'></u>
          <i id='E58EF13CEA'><strike id='E58EF13CEA'><tt id='E58EF13CEA'><pre id='E58EF13CEA'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:6
          Adam's take main illustration
          Molly Ferguson/STAT

          Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

          Gilead needs Arcellx more than ever

          The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

          advertisement

          If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Criminal prosecution for violating HIPAA: an emerging threat
          Criminal prosecution for violating HIPAA: an emerging threat

          BRENDANSMIALOWSKI/AFP/GettyImagesTheterm“HIPAAviolation”canconjureupimagesoflarge-scaledatabreaches.

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Special counsel alerts court to Trump’s social media post

          24:20SpecialcounselJackSmithspeakstomembersofthemediaattheUSDepartmentofJusticebuildinginWashington,